Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 4
2003 1
2006 2
2007 1
2008 1
2009 5
2010 6
2011 1
2012 4
2013 3
2014 4
2016 4
2017 2
2018 2
2019 3
2020 3
2021 5
2022 8
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation.
Gagelmann N, Badbaran A, Salit RB, Schroeder T, Gurnari C, Pagliuca S, Panagiota V, Rautenberg C, Cassinat B, Thol F, Wolschke C, Robin M, Heuser M, Rubio MT, Maciejewski JP, Reinhardt HC, Scott BL, Kröger N. Gagelmann N, et al. Among authors: badbaran a. Blood. 2023 Jun 8;141(23):2901-2911. doi: 10.1182/blood.2023019630. Blood. 2023. PMID: 36940410
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosis.
Fischbach F, Richter J, Pfeffer LK, Fehse B, Berger SC, Reinhardt S, Kuhle J, Badbaran A, Rathje K, Gagelmann N, Borie D, Seibel J, Ayuk F, Friese MA, Heesen C, Kröger N. Fischbach F, et al. Among authors: badbaran a. Med. 2024 Mar 22:S2666-6340(24)00114-4. doi: 10.1016/j.medj.2024.03.002. Online ahead of print. Med. 2024. PMID: 38554710 Free article.
Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M.
Gurnari C, Gagelmann N, Badbaran A, Awada H, Dima D, Pagliuca S, D'Aveni-Piney M, Attardi E, Voso MT, Cerretti R, Wolschke C, Rubio MT, Maciejewski JP, Kröger N. Gurnari C, et al. Among authors: badbaran a. Leukemia. 2023 Mar;37(3):717-719. doi: 10.1038/s41375-023-01820-4. Epub 2023 Jan 28. Leukemia. 2023. PMID: 36709353 No abstract available.
Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy.
Berger SC, Fehse B, Akyüz N, Geffken M, Wolschke C, Janson D, Gagelmann N, Luther M, Wichmann D, Frenzel C, Thayssen G, Alegiani A, Badbaran A, Zeschke S, Dierlamm J, Kröger N, Ayuk FA. Berger SC, et al. Among authors: badbaran a. Haematologica. 2023 Feb 1;108(2):444-456. doi: 10.3324/haematol.2022.281110. Haematologica. 2023. PMID: 35950534 Free PMC article.
Peripheral and Portal Venous KRAS ctDNA Detection as Independent Prognostic Markers of Early Tumor Recurrence in Pancreatic Ductal Adenocarcinoma.
Nitschke C, Markmann B, Walter P, Badbaran A, Tölle M, Kropidlowski J, Belloum Y, Goetz MR, Bardenhagen J, Stern L, Tintelnot J, Schönlein M, Sinn M, van der Leest P, Simon R, Heumann A, Izbicki JR, Pantel K, Wikman H, Uzunoglu FG. Nitschke C, et al. Among authors: badbaran a. Clin Chem. 2023 Mar 1;69(3):295-307. doi: 10.1093/clinchem/hvac214. Clin Chem. 2023. PMID: 36644936
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation.
Gagelmann N, Badbaran A, Beelen DW, Salit RB, Stölzel F, Rautenberg C, Becker H, Radujkovic A, Panagiota V, Bogdanov R, Christopeit M, Park Y, Nibourel O, Luft T, Koldehoff M, Corsten M, Heuser M, Finke J, Kobbe G, Platzbecker U, Robin M, Scott BL, Kröger N. Gagelmann N, et al. Among authors: badbaran a. Blood Adv. 2021 Mar 23;5(6):1760-1769. doi: 10.1182/bloodadvances.2020003600. Blood Adv. 2021. PMID: 33755092 Free PMC article.
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis.
Gagelmann N, Wolschke C, Salit RB, Schroeder T, Ditschkowski M, Panagiota V, Cassinat B, Thol F, Badbaran A, Robin M, Reinhardt HC, Ayuk F, Heuser M, Scott BL, Kröger N. Gagelmann N, et al. Among authors: badbaran a. Blood Adv. 2022 Feb 22;6(4):1222-1231. doi: 10.1182/bloodadvances.2021006827. Blood Adv. 2022. PMID: 35051996 Free PMC article.
62 results